1. Inicio
  2. Proyectos y Estudios
  3. A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3).

A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3).

Datos básicos

ENSAYO CLÍNICO L606-301 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2026

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

LIQUIDIA TECHNOLOGIES, INC.

Cita

Compartir